Drug ID:   | NPD7196 |
Drug Name:   | |
Molecular Formula:   | C29H30N4O8 |
Canonical SMILES:   | N#C[C@H]1[C@@H]2CC3=C([C@@H](N2C)[C@H]2N1[C@@H](CNC(=O)C(=O)C)C1=C(C2)C(=O)C(=C(C1=O)OC)C)C(=O)C(=C(C3=O)C)OC |
Standard InCHI:   | InChI=1S/C29H30N4O8/c1-11-23(35)14-8-17-22-21-15(24(36)12(2)28(41-6)26(21)38)7-16(32(22)4)18(9-30)33(17)19(10-31-29(39)13(3)34)20(14)25(37)27(11)40-5/h16-19,22H,7-8,10H2,1-6H3,(H,31,39)/t16-,17-,18-,19-,22-/m0/s1 |
Standard InCHIKey:   | JNEGMBHBUAJRSX-SHUHUVMISA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
High Similarity | 1.0 | NPC315110 |
Intermediate Similarity | 0.7538 | NPC97861 |
Intermediate Similarity | 0.7424 | NPC161644 |
Intermediate Similarity | 0.7259 | NPC239252 |
Intermediate Similarity | 0.7259 | NPC473703 |
Intermediate Similarity | 0.7174 | NPC473955 |
Intermediate Similarity | 0.705 | NPC25025 |
Remote Similarity | 0.6812 | NPC475987 |
Remote Similarity | 0.6812 | NPC313348 |
Remote Similarity | 0.6794 | NPC13351 |
Remote Similarity | 0.6134 | NPC116231 |
Remote Similarity | 0.6094 | NPC87919 |
Remote Similarity | 0.6084 | NPC315011 |
Remote Similarity | 0.5966 | NPC472161 |
Remote Similarity | 0.575 | NPC475614 |
Remote Similarity | 0.5714 | NPC139867 |
Remote Similarity | 0.5705 | NPC82129 |
Remote Similarity | 0.5645 | NPC236322 |
Molecular Weight   | 562.21 |
ALogP   | -1.0184 |
MLogP   | 3.33 |
XLogP   | -1.99 |
HDA   | 12 |
HBD   | 1 |
Rotatable Bonds   | 12 |
TPSA   | 163.18 |
RO5 Violation   | 1 |